Analyst Ratings for Surgery Partners (SGRY) [Buys]
SGRY Rating Summary
SGRY Price Target Summary
- Highest: $50.00 (Benchmark)
- Lowest: $35.00 (Barclays)
- Average: $41.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.29 (+66.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 69%
Avg. $ Target:
$41.29 (+66.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2023 | TD Cowen » Updated 3/1/2024 |
Gary Taylor | Upgrade | Buy (Hold) |
36.00 (35.00) |
26.70 (24.84) |
-6.97% | Details |
| 6/2/2023 | BofA Securities | Kevin Fischbeck | Upgrade | Buy (Neutral) |
45.00 (42.00) |
38.16 (24.84) |
-34.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
